• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过尸检超声进行微创组织采样:一种(不仅)在传染病中可行的工具——病例报告

Minimally Invasive Tissue Sampling via Post Mortem Ultrasound: A Feasible Tool (Not Only) in Infectious Diseases-A Case Report.

作者信息

Terence Azeke Akhator, Schädler Julia, Ondruschka Benjamin, Steurer Stefan, Möbius Dustin, Fitzek Antonia

机构信息

Department of Anatomic Pathology, Irrua Specialist Teaching Hospital, KM 87 Benin Auchi Rd, Irrua 310115, Nigeria.

Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Butenfeld 34, D-22529 Hamburg, Germany.

出版信息

Diagnostics (Basel). 2023 Aug 10;13(16):2643. doi: 10.3390/diagnostics13162643.

DOI:10.3390/diagnostics13162643
PMID:37627902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10453131/
Abstract

In the past years the number of hospital autopsies have declined steadily, becoming almost excluded from medical training. Medicolegal (forensic) autopsies account for almost all autopsies, whereas hospital autopsies are becoming increasingly rare. Minimally invasive tissue sampling (MITS) using post mortem ultrasound offers the opportunity to increase the number of post mortem examinations in a clinical and even forensic context. MITS is a needle-based post mortem procedure that uses (radiological) imaging techniques to examine major organs of the body, acquire tissue samples and aspirate fluid from the body cavities or hollow organs. In this study, MITS was used to determine the presence of other co-existing diseases in a deceased infected 97-year-old woman with severe acute respiratory syndrome coronavirus 2. The examination of her body was carried out using ultrasound as an imaging tool and to gather ultrasound-guided biopsies as conventional autopsy was rejected by the next of kin. Ultrasound and histology identified an intravesical mass leading to an obstruction of the urinary outlet resulting in bilateral hydronephrosis and purulent pyelonephritis, which was unknown during her lifetime. Histopathological examination revealed the tumor mass to be a squamous cell carcinoma. This study has shown that MITS can be used to determine the cause of death and the presence of concomitant diseases in the infectious deceased.

摘要

在过去几年中,医院尸检的数量稳步下降,几乎已被排除在医学培训之外。法医尸检几乎占了所有尸检,而医院尸检则越来越少见。使用死后超声的微创组织采样(MITS)为在临床甚至法医背景下增加死后检查的数量提供了机会。MITS是一种基于针的死后程序,它使用(放射)成像技术检查身体的主要器官,获取组织样本并从体腔或中空器官中抽吸液体。在本研究中,MITS被用于确定一名感染了严重急性呼吸综合征冠状病毒2的97岁已故女性是否存在其他并存疾病。由于其近亲拒绝进行传统尸检,因此使用超声作为成像工具对她的尸体进行检查,并采集超声引导下的活检样本。超声和组织学检查发现膀胱内有一个肿块,导致尿道口梗阻,进而引起双侧肾积水和脓性肾盂肾炎,而这些情况在她生前并不为人所知。组织病理学检查显示肿瘤肿块为鳞状细胞癌。这项研究表明,MITS可用于确定感染死者的死因和并存疾病的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/10453131/64cc4d28de78/diagnostics-13-02643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/10453131/bd82cbc806f8/diagnostics-13-02643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/10453131/64cc4d28de78/diagnostics-13-02643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/10453131/bd82cbc806f8/diagnostics-13-02643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/10453131/64cc4d28de78/diagnostics-13-02643-g002.jpg

相似文献

1
Minimally Invasive Tissue Sampling via Post Mortem Ultrasound: A Feasible Tool (Not Only) in Infectious Diseases-A Case Report.通过尸检超声进行微创组织采样:一种(不仅)在传染病中可行的工具——病例报告
Diagnostics (Basel). 2023 Aug 10;13(16):2643. doi: 10.3390/diagnostics13162643.
2
Concordance between MITS and conventional autopsies for pathological and virological diagnoses.MITS 与常规尸检在病理和病毒学诊断方面的一致性。
Int J Legal Med. 2024 Mar;138(2):431-442. doi: 10.1007/s00414-023-03088-w. Epub 2023 Oct 14.
3
Ultrasound-Guided Minimally Invasive Tissue Sampling: A Minimally Invasive Autopsy Strategy During the COVID-19 Pandemic in Brazil, 2020.超声引导微创组织取样:2020 年巴西 COVID-19 大流行期间的微创尸检策略。
Clin Infect Dis. 2021 Dec 15;73(Suppl_5):S442-S453. doi: 10.1093/cid/ciab885.
4
Factors Influencing Acceptance of Post-Mortem Examination of Children at a Tertiary Care Hospital in Nairobi, Kenya.肯尼亚内罗毕一家三级保健医院中影响儿童接受尸检因素。
Ann Glob Health. 2019 Jul 3;85(1):95. doi: 10.5334/aogh.2504.
5
Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic examination: a feasibility study.基于尸体磁共振成像和内镜检查相结合的胎儿和儿童微创尸检:一项可行性研究。
Health Technol Assess. 2019 Aug;23(46):1-104. doi: 10.3310/hta23460.
6
Determination of causes of adult deaths using minimally invasive tissue sampling in Gandaki province of Nepal: a multicenter hospital-based study.利用微创组织采样确定尼泊尔甘达基省成人死亡原因:一项多中心医院为基础的研究。
Eur J Med Res. 2023 Oct 7;28(1):407. doi: 10.1186/s40001-023-01392-0.
7
Minimally Invasive Tissue Sampling as an Alternative to Complete Diagnostic Autopsies in the Context of Epidemic Outbreaks and Pandemics: The Example of Coronavirus Disease 2019 (COVID-19).在疫情和大流行背景下,微创组织取样作为完全诊断性尸检的替代方法:以 2019 年冠状病毒病(COVID-19)为例。
Clin Infect Dis. 2021 Dec 15;73(Suppl_5):S472-S479. doi: 10.1093/cid/ciab760.
8
Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.12 例新型冠状病毒病患者微创组织采样结果。
Clin Infect Dis. 2021 Dec 15;73(Suppl_5):S454-S464. doi: 10.1093/cid/ciab812.
9
Hypothetical acceptability of hospital-based post-mortem pediatric minimally invasive tissue sampling in Malawi: The role of complex social relationships.马拉维基于医院的死后儿科微创组织采样的假设可接受性:复杂社会关系的作用。
PLoS One. 2021 Feb 4;16(2):e0246369. doi: 10.1371/journal.pone.0246369. eCollection 2021.
10
Multimodality minimally invasive autopsy--a feasible and accurate approach to post-mortem examination.多模态微创尸检——一种可行且准确的死后检查方法。
Forensic Sci Int. 2010 Feb 25;195(1-3):93-8. doi: 10.1016/j.forsciint.2009.11.019. Epub 2009 Dec 24.

引用本文的文献

1
Exploring minimally invasive tissue sampling as an alternative to conventional autopsy in neonatal deaths.探索微创组织取样作为新生儿死亡常规尸检的替代方法。
Forensic Sci Med Pathol. 2025 Aug 21. doi: 10.1007/s12024-025-01069-6.

本文引用的文献

1
Robotic Tissue Sampling for Safe Post-Mortem Biopsy in Infectious Corpses.用于感染尸体安全尸检活检的机器人组织采样
IEEE Trans Med Robot Bionics. 2022 Jan 26;4(1):94-105. doi: 10.1109/TMRB.2022.3146440. eCollection 2022 Feb.
2
Postmortem Antigen-Detecting Rapid Diagnostic Tests to Predict Infectivity of SARS-CoV-2-Associated Deaths.尸检抗原检测快速诊断试验预测 SARS-CoV-2 相关死亡的传染性。
Emerg Infect Dis. 2022 Jan;28(1):244-247. doi: 10.3201/eid2801.211749. Epub 2021 Nov 2.
3
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases.
735 例连续 SARS-CoV-2 相关死亡病例的前瞻性尸检评估。
Sci Rep. 2021 Sep 29;11(1):19342. doi: 10.1038/s41598-021-98499-3.
4
Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients' Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs.COVID-19患者角膜上皮、结膜和鼻咽拭子中SARS-CoV-2 RNA的死后逆转录聚合酶链反应检测
J Clin Med. 2021 Sep 20;10(18):4256. doi: 10.3390/jcm10184256.
5
The handling of SARS-CoV-2 associated deaths - infectivity of the body.与 SARS-CoV-2 相关死亡的处理方式 - 尸体的传染性。
Forensic Sci Med Pathol. 2021 Sep;17(3):411-418. doi: 10.1007/s12024-021-00379-9. Epub 2021 Jun 2.
6
Persistence of SARS-CoV-2 Viral RNA in Nasopharyngeal Swabs after Death: An Observational Study.SARS-CoV-2病毒RNA在死亡后鼻咽拭子中的持续存在:一项观察性研究。
Microorganisms. 2021 Apr 10;9(4):800. doi: 10.3390/microorganisms9040800.
7
Minimally Invasive Autopsy Practice in COVID-19 Cases: Biosafety and Findings.COVID-19 病例中的微创尸检实践:生物安全与发现
Pathogens. 2021 Apr 1;10(4):412. doi: 10.3390/pathogens10040412.
8
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19: A Review of Literature.胸部 CT 成像在疑似或确诊 COVID-19 患者中的应用:文献复习。
Chest. 2021 Aug;160(2):652-670. doi: 10.1016/j.chest.2021.04.004. Epub 2021 Apr 20.
9
COVID-19 lungs in post-mortem computed tomography.新冠病毒肺炎患者尸体解剖计算机断层扫描结果
Rechtsmedizin (Berl). 2021;31(2):145-147. doi: 10.1007/s00194-021-00462-z. Epub 2021 Feb 15.
10
Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19.《COVID-19 病毒血症患者角膜中存在 SARS-CoV-2 RNA》
JAMA Ophthalmol. 2021 Apr 1;139(4):383-388. doi: 10.1001/jamaophthalmol.2020.6339.